Endometriosis New Zealand is welcoming Pharmac's decision to publicly fund desogestrel, a move that will significantly improve access to this important treatment option for people living with ...

"This decision will be a major boost for many New Zealanders affected by endometriosis," says Tanya Cooke, Chief Executive of Endometriosis New Zealand. "For far too long, access to desogestrel, which ...